Clinical Trial Update: Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study of CD19 CAR-γδ T cells in relapsed/refractory autoimmune nephropathy, targeting membranous nephropathy, lupus nephriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy
• Lupus Nephritis
• Membranous Nephropathy

Drugs mentioned

• CD19 CAR T cells

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Membranous Nephropathy, Lupus Nephritis (LN) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING